Tripathi B J, Tripathi R C, Millard C B
Eye Research Laboratories, University of Chicago, Illinois 60637.
Lens Eye Toxic Res. 1989;6(1-2):141-56.
To investigate the possible side effects of epinephrine on the aqueous outflow pathway, we studied the response of human trabecular cells in vitro exposed daily to the drug at various concentrations. Epinephrine at 10(-6) M caused abnormal cytokinesis and cell retraction, inhibited mitosis and phagocytosis, and induced a 4- to 5-fold increase in cAMP. After 7-10 days of exposure, notable degenerative changes were observed in the trabecular cells. Within certain limits, these effects were reversible when the drug was withdrawn. Exposure to epinephrine at 10(-5) M caused cell death within 96 hours. When a 10(-7) M concentration of epinephrine was administered for up to 10 days, no degenerative changes were seen, but mitotic activity was reduced somewhat. Pretreatment with timolol reduced, but did not completely eliminate, the cytotoxic effects of epinephrine. Cells with loose contact to the substrate were affected most. The morphologic changes and the observed loss of intracellular actin filaments indicate that the deleterious effects of epinephrine are probably mediated through damage to cellular contractile proteins. Although the precise cytotoxic action of epinephrine in vivo remains to be established, our results for primary cell cultures indicate a toxic action of this drug at concentrations of 10(-6) M or higher on human trabecular cells and suggest that, for prolonged use, the maximal dose of this drug at target sites should be in the region of 10(-7) M.
为了研究肾上腺素对房水流出途径可能产生的副作用,我们对体外培养的人小梁细胞进行了研究,这些细胞每天暴露于不同浓度的该药物中。10⁻⁶ M的肾上腺素会导致异常的胞质分裂和细胞收缩,抑制有丝分裂和吞噬作用,并使环磷酸腺苷(cAMP)增加4至5倍。暴露7至10天后,小梁细胞中观察到明显的退行性变化。在一定限度内,停药后这些效应是可逆的。暴露于10⁻⁵ M的肾上腺素会在96小时内导致细胞死亡。当给予10⁻⁷ M浓度的肾上腺素长达10天时,未见退行性变化,但有丝分裂活性略有降低。用噻吗洛尔预处理可降低肾上腺素的细胞毒性作用,但不能完全消除。与底物接触松散的细胞受影响最大。形态学变化以及观察到的细胞内肌动蛋白丝的丢失表明,肾上腺素的有害作用可能是通过对细胞收缩蛋白的损伤介导的。尽管肾上腺素在体内的确切细胞毒性作用尚待确定,但我们对原代细胞培养的结果表明,该药物在浓度为10⁻⁶ M或更高时对人小梁细胞具有毒性作用,并提示,对于长期使用,该药物在靶部位的最大剂量应在10⁻⁷ M左右。